APPLICATION
ANDA072707
TYPE
ANDA
ORIGINAL APPROVAL
1989-03-15
LATEST ACTION
2001-09-06
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued
Products
PRAZOSIN HYDROCHLORIDEDiscontinued
PRAZOSIN HYDROCHLORIDE EQ 5MG BASE · CAPSULE · ORAL
Approval history
2001-09-06Manufacturing (CMC) · Supplement 9AP
2001-09-06Manufacturing (CMC) · Supplement 10AP
1998-10-06Manufacturing (CMC) · Supplement 8AP
1995-05-11Manufacturing (CMC) · Supplement 5AP
1994-07-28Manufacturing (CMC) · Supplement 6AP
1994-06-28Manufacturing (CMC) · Supplement 7AP
1992-01-22Manufacturing (CMC) · Supplement 1AP
1992-01-22Manufacturing (CMC) · Supplement 2AP
1991-01-17Labeling · Supplement 4AP
1989-03-15OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.